# US 2011/0206603 A1 · Particulate materials and compositions for radio therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0206603 A1
- Document ID: US20110206603A1
- Status: Published application
- Kind: A1
- Application number: 13/030,778
- Filed: 2011-02-18
- Published: 2011-08-25
- Earliest claimed: 2004-03-05
- Assignees: XL Sci-Tech, Inc.
- Inventors: Yongren Benjamin PENG; Xingye Cherry Lei
- Web page: https://patentgrep.com/patent/US20110206603A1

## CPC

- A61K 51/1217: {Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols}
- A61N 5/1027: {Interstitial radiation therapy}
- A61K 51/1251: {micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules}
- A61K 51/1255: {Granulates, agglomerates, microspheres}
- A61L 27/425: {of phosphorus containing material, e.g. apatite}
- A61L 27/427: {of other specific inorganic materials not covered by A61L27/422 or A61L27/425}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/58: Materials at least partially resorbable by the body
- A61P 35/00: Antineoplastic agents
- A61L 2300/44: Radioisotopes, radionuclides
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Timed-bioresorbable particulates, particularly microspheres or fibers, may be used as a vehicle for delivery of radioisotopes, such as Y-90 and Pd-103 for localized radiotherapy, or as an embolic device. These particulates may also be embedded in polymers, or dispersed in injectable gels or other injectable media for the treatment of various cancers. The benefit of bioresorption, the ability to control the ratio of radioisotopes in the particulate, especially the gamma and beta ratios such as In-111/Y-90 ratio in a particulate, and the benefit of non-conductive implants are disclosed.

## Claims

### Claim at position 1

1-35. (canceled)

### Claim 36

A therapeutic and/or diagnostic implant material comprising
(a) a base matrix comprising oxides, oxides containing nitrogen, nitrides, or combinations thereof; and
(b) an imaging enhancing agent, radiographical detection agent, radiographical marker, or x-ray opaque marker of said implant,
wherein said implant material is non-conductive.

### Claim 37 (depends on 36)

The method of claim 36, wherein the implant material further comprises a radioactive isotope or combination of radioisotopes.

### Claim 38 (depends on 37)

The implant material of claim 37, wherein the radioactive isotope or combination of radioisotopes is Y-90, In-111, Pd-103, P-32, Cs-131, Sm-153, Ho-166, Tc-99m, Yb-169, Au-198, Re-188, Re-186, Ir-192, Lu-177, Ba-140, Se-72, I-131, I-125, Sr-90, Dy-165, Er, Tl, Sr, Gd, Y-90/In-111, Y-90/Tc-99m, P-32/In-111, P-32/Tc-99m, Ho-166/In-111, Ho-166/Tc-99m, Sm-153/In-111, Sm-153/Tc-99m, or combinations thereof.

### Claim 39 (depends on 37)

The implant material of claim 37, wherein the radioactive isotope or combination of radioisotopes are distributed homogeneously throughout the implant material.

### Claim 40 (depends on 37)

The implant material of claim 37, wherein said radioactive isotope or combination of radioisotopes is present in an amount effective for radiation therapy of a tumor.

### Claim 41 (depends on 36)

The implant material of claim 36, wherein said matrix is a particulate, microsphere, porous microsphere, hollow microsphere, microcapsule, fiber, solid fiber, small rod, particulate dispersed in biopolymers, particulate dispersed in bioresorbable sutures, particulate dispersed in biocompatible gels, particulate dispersed in other media, or combinations thereof.

### Claim 42 (depends on 36)

The implant material of claim 36, wherein said implant material is embedded or encapsulated in a non-conductive delivery vehicle.

### Claim 43 (depends on 42)

The implant material of claim 42, wherein said non-conductive delivery vehicle is a biopolymer, bioresorbable suture, injectable gel, tissue adhesive, other media, or combinations thereof.

### Claim 44 (depends on 43)

The implant material of claim 43, wherein said biopolymer is poly-1-lactic acid in the molecular weight range of 30,000 to 500,000, poly-1-lactic acid co-polymers with polyglycolic acid, polydioanone (PDS II), polyglycaprone 25 (Moncryl), polyglactin 910 (Vicryl), phenyletheretherketone (PEEK), polysulfone (PSL, polyurethane, polypropylene, silicone, polyethylene terephthalate (PET), polyphenylene oxide blends (PPO), polyphenylsulfone (PPSU), polyether sulfone (PES), polyphenylene sulfide (PPS), polyetherimide (PEI), liquid crystal polymer (LCP), or combinations thereof.

### Claim 45 (depends on 36)

The implant material of claim 36, wherein the implant material comprises a nitrogen-rich surface layer.

### Claim 46 (depends on 45)

The implant material of claim 45, wherein the nitrogen-rich surface layer comprises about 15% molar nitrogen.

### Claim 47 (depends on 36)

The implant material of claim 36, wherein the base matrix does not need or require high energy particle irradiation to convert one or more stable isotopes into radioactive isotopes.

### Claim 48 (depends on 36)

The implant material of claim 36, wherein the imaging enhancing agent is Fe, Gd, or combinations thereof.

### Claim 49 (depends on 36)

The implant material of claim 36, wherein the radiographical detection agent or radiographical marker is Ba, Zn, or combinations thereof.

### Claim 50 (depends on 36)

The implant material of claim 36, wherein the implant material is 100 to 1000 micrometers in diameter.

### Claim 51

A method of radiation therapy or diagnostics comprising administering or implanting into a patient a non-conductive implant comprising (a) a base matrix comprising oxides, oxides containing nitrogen, nitrides, or combinations thereof; and (b) an imaging enhancing agent, radiographical detection agent, radiographical marker, or x-ray opaque marker of said implant.

### Claim 52 (depends on 51)

The method of claim 51, wherein the implant is 1 to 80 micrometers in diameter.

### Claim 53 (depends on 52)

The method of claim 52, wherein the implant is suspended in a viscous medium.

### Claim 54 (depends on 53)

The method of method of claim 53, wherein the viscous medium is pyrogen-free 85% glycerol or iodized lipiodol.

### Claim 55 (depends on 51)

The method of claim 51, wherein the implant is injected, implanted, or inserted at a tumor site.

### Claim 56 (depends on 55)

The method of method of claim 55, wherein the site is a joint, prostate, breast, liver, pancreas or other soft-tissue tumors.

### Claim 57 (depends on 55)

The method of claim 55, wherein the implant further comprises a radioactive isotope or combination of radioisotopes.

### Claim 58 (depends on 51)

The method of claim 51, further comprising real-time monitoring and/or real-time dosimetry.
